Metabolic Cardiovascular Syndrome
14
2
2
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.1%
1 terminated out of 14 trials
90.0%
+3.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Fermented Plant-based Portfolio Diet 4 Metabolic Health
Metabolic Effects of Angiotensin-(1-7)
Cardiometabolic evalUation REgistry of Heart Failure
Plant-based Diets and Body Weight and Selected Metabolic Parameters Management in Obese Patients.
The Effects of Psyllium Seed on Body Weight and Metabolic Syndrome Indicators in Patients with Schizophrenia
Incidence of Metabolic Syndrome in People Living With HIV Without ExperienCe to ART Who Start DoLutegravir Based-Regimen Compared With BictegrAvir Based-RegimeN
Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2
Phlebotomy and Polycystic Ovary Syndrome
Health Improvement After Pregnancy (HIP) Program Randomized Control Trial
Magnesium and Metabolic Syndrome: A Dose-response Meta-analysis
Home Bicycle Exercise and Aerobic Capacity
Cluster Analysis of the Risk of Metabolic Syndrome in Women for Reproductive Age
Hyperinsulinemic Euglycemic Clamp Protocol
Metabolic Syndrome Diagnosis and Education Trial